2004December 14, 2004Codexis Announces the Signing of Research Collaboration with Teva to Develop Improved Pharmaceutical Biosyntheses December 3, 2004Maxygen announces new development program and product development prioritization October 26, 2004Maxygen Reports Third Quarter 2004 Financial Results October 25, 2004Maxygen to Webcast Presentation at the Rodman and Renshaw Techvest 6th Annual Healthcare Conference October 19, 2004Maxygen to Webcast Third Quarter 2004 Earnings Conference Call on October 26, 2004 October 11, 2004Maxygen to Webcast Presentation at the BIO Emerging Company Investor Forum Conference September 21, 2004Maxygen to Webcast Presentation at the UBS Global Life Sciences Conference September 9, 2004Maxygen and Rentschler Sign Agreement to Manufacture Novel G-CSF July 27, 2004Maxygen Reports Second Quarter 2004 Financial Results July 2, 2004DuPont Completes Purchase of Maxygen Subsidiary Verdia June 8, 2004Maxygen and Biovitrum Sign Agreement to Manufacture Optimized Beta Interferon for Phase I and II Clinical Trials June 3, 2004DuPont To Acquire Maxygen Subsidiary Verdia May, 20, 2004Maxygen Subsidiary Verdia Announces Discovery and Improvement of Glyphosate Tolerance Gene April 27, 2004Maxygen Reports First Quarter 2004 Financial Results and Progress of Product Pipeline April 20, 2004Maxygen to Webcast First Quarter 2004 Earnings Conference Call on April 27, 2004 February 23, 2004Maxygen, Inc. Announces Webcast of Corporate Presentation at the 6th Annual BIO CEO & Investor Conference February 10, 2004Maxygen Reports Fourth Quarter and Year End 2003 Financial Results February 03, 2004Maxygen to Webcast Year-End 2003 Earnings Conference Call on February 10, 2004 January 13, 2004Maxygen Announces Webcast of Presentation at 22nd Annual JPMorgan Healthcare Conference
Return to News
|
